Please try another search
For the fiscal year ended 31 December 2015, Targeted Medical Pharma Inc revenues decreased 26% to $5.3M. Net loss decreased 22% to $3M. Revenues reflect Product Revenue decrease of 27% to $4.7M, Service Revenue decrease of 19% to $523K. Lower net loss reflects Research and Development decrease of 92% to $12K (expense), Change in fair value of derivative liabi increase from $11K to $136K (income), Interest expense decrease of 5% to $1.2M (expense).
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Total Revenue | 1.29 | 1.56 | 1.34 | 1.07 |
Gross Profit | 0.78 | 1.06 | 0.81 | 0.52 |
Operating Income | -0.37 | -0.02 | -0.37 | -1.27 |
Net Income | -0.58 | -0.24 | -0.55 | -1.68 |
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Total Assets | 2.43 | 2.45 | 2.4 | 2.8 |
Total Liabilities | 15.32 | 14.78 | 14.51 | 14.42 |
Total Equity | -12.9 | -12.33 | -12.11 | -11.62 |
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -1.28 | -1.36 | -1.49 | -1.46 |
Cash From Investing Activities | -0 | |||
Cash From Financing Activities | 1.35 | 1.36 | 1.5 | 1.68 |
Net Change in Cash | 0.07 | 0.01 | 0.01 | 0.21 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review